The efficacy and safety of conventional transcatheter arterial chemoembolization combined with PD-1 inhibitor and anti-angiogenesis tyrosine kinase inhibitor treatment for patients with unresectable hepatocellular carcinoma: a real-world comparative study

AIM: We sought to evaluate the efficacy and safety of conventional transcatheter arterial chemoembolization (cTACE) sequentially combined with systemic treatment by programmed cell death protein 1 (PD-1) inhibitor and anti-angiogenesis tyrosine kinase inhibitor (Anti-angiogenesis TKI) in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Zheng, Zhu, Huabin, Zhang, Xiufang, Huang, Li, Wang, Xiangcai, Shi, Huaqiu, Yu, Li, Qiu, Yingwei, Tu, Fuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558003/
https://www.ncbi.nlm.nih.gov/pubmed/36248989
http://dx.doi.org/10.3389/fonc.2022.941068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558003/
https://www.ncbi.nlm.nih.gov/pubmed/36248989
http://dx.doi.org/10.3389/fonc.2022.941068

Ejemplares similares